Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
16 Apr 2015 ELCC 2015 News: Neoadjuvant Erlotinib in Endobronchial Ultrasound Confirmed Stage IIIA-N2 NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Apr 2015 ELCC 2015 News: Promising Results for Surgical Salvage of Local Recurrences after Stereotactic Ablative Radiotherapy in Patients With Early-Stage NSCLC Personalised medicine - Translational research - Lung and other thoracic tumours
16 Apr 2015 ELCC 2015 News: EGFR Mutation Detection Possible from Ultrasound-Guided Fine Needle Aspirates Taken from Patients with Lung Cancer Translational research - Lung and other thoracic tumours
16 Apr 2015 ELCC 2015 News: Brigatinib (AP26113) Shows Intracranial Anti-tumour Activity in ALK-positive NSCLC patients with Brain Metastasis Following Crizotinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Apr 2015 ELCC 2015 News: VEGF SNPs Identified as Prognostic Markers for Bevacizumab Response in Patients with Advanced Non-Squamous NSCLC Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
06 Mar 2015 FDA Expands Approved Use of Nivolumab to Squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
11 Feb 2015 Common vs. Rare EGFR Mutations in Lung Adenocarcinoma Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Jan 2015 Annals of Oncology Press Release: Lung Cancer Predicted to Overtake Breast Cancer as Leading Cause of Cancer Death Among European Women in 2015 Lung and other thoracic tumours
26 Jan 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Protein Bound Paclitaxel Lung and other thoracic tumours - Anticancer agents & Biologic therapy
09 Jan 2015 Stereotactic Body Radiation Therapy Plus Erlotinib for Stage IV Limited, but Progressive, Metastatic NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Dec 2014 FDA Approves Ramucirumab for Treatment of Metastatic NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
12 Nov 2014 Lung Cancer Screening with Low-Dose CT Could Be Cost Effective Bioethics, legal and economic issues - Epidemiology/Etiology/Cancer Prevention - Lung and other thoracic tumours
30 Oct 2014 Study May Explain Why Erlotinib Doesn't Benefit Patients With Early-Stage Lung Cancer Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
06 Oct 2014 ESMO 2014: New Data on First- and Second-Line ALK Inhibition in NSCLC Patients Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Sep 2014 European Medicines Agency Recommends Granting a Marketing Authorisation for Nintedanib Lung and other thoracic tumours - Anticancer agents & Biologic therapy